Apimeds Pharmaceuticals US Inc.通过引入两位资深高管强化了领导层。Susan Kramer博士被任命为开发高级副总裁，其在生物制药研究领域拥有逾30年丰富经验。Brian Peters担任ai²部门负责人，将主导公司创新平台的战略规划与推出。Kramer将全面管理产品开发活动，而Peters则专注于ai²平台的战略举措。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.